Screening for high risk human papilloma virus (HR-HPV) subtypes, among sudanese patients with oral lesions

International Journal of Clinical and Experimental Medicine

Volumn 6, Issue 4, 2013, Pages 275-281

  Yousif Babiker, Ali ^a   Margani Eltom, Faris ^a   Abdalaziz, Mohamed S ^a   Rahmani, Arshad ^b   Abusail, Saadalnour ^c   Gadelkareem Ahmed, Hussain ^d  

^a Sudan University for Science and Technology   (Sudan)

^b QASSIM UNIVERSITY   (Saudi Arabia)

^c University of Elneelain   (Sudan)

^d UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

HR HPV; Oral lesions; PCR; Smoking; Toombak

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; MALE; MOUTH CANCER; MOUTH LESION; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SCREENING; SUDAN;

EID: 84877246828     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Nelson L and Rhodus N. Oral cancer: Leukoplakia and squamous cell carcinoma. Dent clin N Am 2005; 49: 143-165.
2. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer, Oral Oncol 2009; 45: 309-316.
3. Marchioni DM, Fisberg RM and De Góis Filho F. Fatores dietéticos e câncer oral: estudo casocontrole na Região Metropolitana de São Paulo, Brasil. Cadernos de Saúde Pública 2007; 23: 553-564.
4. Ahmed HG and Mahgoob RM. Impact of Toombak dipping in the etiology of oral cancer: Genderexclusive hazard in the Sudan. J can Res Ther 2007; 3: 127-130.
5. Scully C. Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission. Oral Oncol 2002; 38: 227-234.
6. Mayne ST, Morse DE and Winn DM. Cancers of the oral cavity and pharynx. In: Schottenfeld D, Fraumeni JF (eds). Cancer epidemiology and prevention. 3rd Ed. New York: Oxford University Press; 2006. pp: 674-696.
7. zur Hausen H. Viruses in human cancers. Science 1991; 254: 1167-1171.
8. Ahmed HG and Eltoom FM. Detection of human papilloma virus Types 16 and 18 among Sudanese patients with Oral Squamous Cell Carcinoma. Cancer Journal 2010; 3: 130-134.
9. El-Naggar AK and Reichart PA. Proliferative verrucous leukoplakia and precancerous conditions. In Barnes L, Eveson JW, Reichart P, Sidranski D eds. Pathology and genetics head and neck tumour. Lyon: World Health Classification of Tumors; 2005. pp: 180-181.
10. Nisreen SA, Mehdi SJ, Shabbir AM, Ali A, Mandal AK, Gupta S, Singh I and Rizvi MA. PTENmediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients. J Cancer Res Clin Oncol 2012; 138: 103-109.
11. Kreimer AR, Clifford GM, Boyle P and Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475.
12. Warnakulasuriya S, Sutherland G and Scully C. Tobacco, oral cancer, and treatment of dependence. Oral Oncol 2005; 41: 244-260.
13. Blot WJ, McLaughlin JK and Winn DM. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1998; 48: 3282-7.
14. Warnakulasuriya S, Trivedy C and Peters TJ. Areca nut use: an independent risk factor for oral cancer. BMJ 2002; 324: 799-800.
15. Ibrahim SO, Lillehaug JR, Dolphine O, Johnson NW, Warnakulasuriya KA and Vasstrand EN. Mutations of the cell cycle arrest gene p21WAF1, but not the metastasis-inducing gene S100A4, are frequent in oral squamous cell carcinomas from Sudanese Toombak dippers and non-snuff-dippers from the Sudan, Scandinavia, USA and UK. Anticancer Res 2002; 22: 1445-51.
16. Ibrahim SO, Vasstrand EN, Johannessen AC, Idris AM, Magnusson B, Nilsen R, Lillehaug JR. Mutations of the p53 gene in oral squamouscell carcinomas from Sudanese dippers of nitrosaminerich Toombak and non-snuff-dippers from the Sudan and Scandinavia. Int Cancer 1999; 81: 527-34.
17. Loro LL, Vintermyr OK, Ibrahim SO, Idris AM and Johannessen AC. Apoptosis and expression of Bax and Bcl-2 in snuff- and non-snuff associated oral squamous cell carcinomas. Anticancer Res 2000; 20: 2855-60.
18. Ginawi IM, Mahgoub EA and Ahmed HG. Immunophenotyping of HPV Types 16 and 18 among Sudanese Patients with Oral Lesions. Oman Med J 2012; 27: 196-200.
19. Ibieta BR, Lizano M and Frias-Mendivil M. Human papilloma virus in oral squamous cell carcinoma in a Mexican population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 311-5.
20. Horstmann M, Witthuhn R, Falk M and Stenzl A. Gender-specific differences in bladder cancer: A retrospective analysis. Gend Med 2008; 5: 385-394.
21. Gillison ML, Broutian T, Pickard RK. Prevalence of oral HPV infection in the United States. JAMA 2012; 307: 693-703.
22. Rahmani A, Alzohairy M, Babiker AY, Rizvi MA and Ahmed HG. Clinicopathological significance of PTEN and bcl2 expressions in oral squamous cell carcinoma. Int J Clin Exp Pathol 2012; 5: 965-971.
23. Guily LS, Jacquard AC, Prétet JL, Haesebaert J, Beby-Defaux A, Clavel C, Agius G, Birembaute P, Claire O, nYann L, Benoît S, Pierre P, Didier R, Christiane M and O. Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France. J Clin Virol 2011; 51: 100-104.
24. D'Souza G, Kreimer AR and Viscidi R. Casecontrol study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-1956.
25. Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M and Giraud G. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viralinduced carcinoma? Int J Cancer 2009; 125: 362-6.
26. Ahmed HG, Abusail SA and Warille E. Human papilloma virus attributable head and neck cancer in the Sudan assessed by p16INK4A immunostaining. Asian Pac J Cancer Prev 2012; 13: 438994-5.
27. Ahmed HG, Abusail SM, Eltom FM and Babiker AY. Frequency and genotype of human papillomavirus among Sudanese patients with head and neck tumors. Ecancer 2012; 6: 282.
28. IARC. Cancer incidence and mortality worldwide in 2008: World health organization.
29. Wei W, Shi Q, Guo F, Zhang BY, Chen C and Zhang NS. The distribution of human papillomavirus in tissues from patients with head and neck squamous cell carcinoma. Oncol Rep 2012; 28: 1750-6.
30. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X and Shah KV. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
31. Montaldo C, Mastinu A, Quartuccio M, Piras V, Denotti G, Pisano E and Orrù G. Detection and genotyping of human papillomavirus DNA in samples from healthy Sardinian patients: a preliminary study. J Oral Pathol Med 2007; 36: 482-7.
32. Adelstein DJ, Ridge JA and Gillison ML. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, Washington, D.C. Head Neck 2009; 31: 1393-1422.
33. Gillison M, Koch W, Capone R, Spafford M, Westra W, Wu L, Zahurak M, Daniel R, Viglione M, Symer D, Shah K and Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 675-677.
34. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernandez L, Idris A, Sanchez MJ, Nieto A, Talamini R, Tavani A, Bosch FX, Reidel U, Snijders PJ, Meijer C, Viscidi R, Munoz N and Franceschi S. IARC Multicenter Oral Cancer Study Group Human papillomavirus and oral cancer: the International Agency for Research on Cancer Multicenter Study. J Natl Cancer Inst 2003; 95: 1772-1783.
35. Gillison M. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004; 31: 744-754.